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ADP-ATP exchange by the molecular chaperone
Hsp70 is enhanced by several cochaperones. BAG5
consists of five BAG domains and associates with
the nucleotide-binding domain (NBD) of Hsp70. The
overexpression of BAG5 in the cytosol reportedly
disturbs Hsp70-mediated protein refolding and
induces Parkinson’s disease. In the present study,
we found that the fifth BAG domain (BD5) of BAG5
is responsible for the interaction between Hsp70
and BAG5.We also determined the crystal structures
of the BD5NBD complex. BD5 binding caused two
different types of NBD conformational changes,
which both disrupted the nucleotide-binding groove.
In fact, BD5 reduced the affinity of the NBD for ADP.
Moreover, BD5, as well as the full-length BAG5,
accelerated Hsp70-mediated refolding in an in vitro
assay. Therefore, BAG5 can function as the nucleo-
tide exchange factor of Hsp70 for the enhancement
of protein refolding.
INTRODUCTION
The 70 kDa heat shock proteins (Hsp70s) are ubiquitous and
abundant molecular chaperones for all organisms. They include
the stress-induced Hsp70 and the housekeeping Hsc70, which
assist in the correct folding of denatured and/or nascent proteins,
to prevent protein aggregation (Bukau et al., 2006; Hartl and
Hayer-Hartl, 2002; Mayer and Bukau, 2005). Hsp70s are
composed of the N-terminal nucleotide-binding domain (NBD)
and the C-terminal substrate-binding domain (SBD) (Figure 1A).
Hsp70s in the ATP-bound state catch and release their
substrates rapidly, while Hsp70s in the ADP-bound state seize
themfirmly. By cycling between theATP- andADP-bound states,
Hsp70s exert their chaperone activity (Bukau and Horwich,
1998). The ATP hydrolysis activity of Hsp70s converts the ATP-
bound state to the ADP-bound state. The J cochaperones recruit
the substrate to the ATP-bound Hsp70s and enhance the ATPStructure 18, 3hydrolysis activity (Misselwitz et al., 1998; Walsh et al., 2004).
After ATP hydrolysis, Hsp70s can release ADP by themselves,
via the interaction between the NBD and SBD (Jiang et al.,
2005), but the release rate is quite slow. Therefore, in this step,
Hsp70s use nucleotide exchange factors (NEFs), such as GrpE
(Liberek et al., 1991) in bacteria and the Hsp110s (Andreasson
et al., 2008; Dragovic et al., 2006; Raviol et al., 2006; Shaner
et al., 2006) and HspBP1/Fes1/Sls1 (Kabani et al., 2002) in
eukaryotes. The interaction of the NEFs with the NBD facilitates
the release of ADP, accelerates the ATP cycle, and activates
the refolding activity of Hsp70 (Harrison et al., 1997; Polier
et al., 2008; Schuermann et al., 2008; Shomura et al., 2005).
The Bcl-2-associated athanogene (BAG) family is one of the
Hsp70NEF familiesand is evolutionally conservedamongeukary-
otes (Kabbage and Dickman, 2008; Takayama and Reed, 2001).
The human BAG family consists of six members, BAG1, BAG2,
BAG3 (CAIR-1/Bis), BAG4 (SODD), BAG5, and BAG6 (Scythe/
BAT3) (Takayama et al., 1995, 1999; Thress et al., 1998). The
BAG domain (BD) of BAG1 is composed of 112 residues and
forms three almost parallel a helices (Briknarova´ et al., 2001). In
the early stage of research, the effect of BAG1 on the chaperon
activity of Hsp70 was not clarified and reported to be either posi-
tive (Ho¨hfeld and Jentsch, 1997; Gassler et al., 2001) or negative
(Bimston et al., 1998; Nollen et al., 2001; Takayama et al., 1997).
However, the crystal structure of a complex between the BAG1
BD and the Hsc70 NBD revealed that the BAG1 BD induces the
conformational changeof theNBD to theopenstateand facilitates
ADP release (Sondermannet al., 2001). TheBD is thereby respon-
sible for the NEF activity of BAG1. In contrast, BAG2 lacks the
BD, but contains the brand new BAG (BNB) domain, which is
also composed of three non-parallel a helices (Xu et al., 2008).
Bindingof theBAG2BNBdomain toHsc70NBDcausesadifferent
type of conformational change in the NBD, which also facilitates
ADP dissociation (Xu et al., 2008). In contrast, BAG3, BAG4, and
BAG5 conserve the BD, which consists of three parallel a helices,
but is about 25 residues shorter than the BAG1 BD (Figure 1B)
(Briknarova´ et al., 2002; Brockmann et al., 2004). No NBD
complex structure is currently available for these shorter BDs.
BAG5 is a unique BAG protein, because BAG5 contains five
shorterBDs in tandem (Figure 1A) (Briknarova´ et al., 2002).BAG5-
overexpression state reduces the cellular Hsp70-mediated
refolding activity. In addition to the BAG5-induced inhibition of09–319, March 10, 2010 ª2010 Elsevier Ltd All rights reserved 309
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Figure 1. Crystal Structure of the BAG5 BD5
and Hsp70 NBD Complex
(A) Domain structures of human Hsp70 and BAG5.
Hsp70 is composed of the NBD (cyan) and SBD
(green), and BAG5 has five BDs (orange), desig-
nated as BD1, BD2, BD3, BD4, and BD5.
(B) In vitro pull-down assay, using the His-BAG5
full-length (FL), BD1 (residues 1–89), BD2–3 (resi-
dues 86–260), BD4 (residues 275–350), and BD5
(residues 341–447) and the purified Hsp70 NBD
(residues 1–388). In the lane labeled ‘‘input,’’ only
purified Hsp70 NBD was loaded.
(C) Secondary structures of the BAG1 BD and
BAG5 BD5, and sequence alignment of the BDs
in human BAG1, BAG3, BAG4, and BAG5.
(D) Crystal structure of the BD5NBD complex. The
asymmetric unit contains twocomplexes, designed
as complexes A and B. The green and cyan ribbon
diagrams represent the Hsp70 NBD, and the
magenta and orange ribbon diagrams represent
theBAG5BD5.Molecular graphicswere generated
and rendered using the program PyMOL (DeLano
Scientific). As shown Figure S1, we detected no
nucleotide in the BD5NBD complex.
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BAG5-Dependent ADP-ATP Exchange of Hsp70parkin E3 ligase, the overexpression of BAG5 promotes protein
aggregation in dopaminergic neurons and causes the neurode-
generation associated with endoplasmic reticulum stress, which
leads to Parkinson’s disease (Chung and Dawson, 2004; Kalia
et al., 2004). In contrast, BAG5 is expressed in multiple tissues
in rat and human (Kalia et al., 2004) and its function in the normal
state has not been elucidated.
In thepresent study,we found that the fifth BD (BD5) of BAG5 is
responsible for the binding of BAG5 to theHsp70NBD.Wedeter-
mined the crystal structure of theBD5NBDcomplex. Therewere
two complexes in the asymmetric unit. In one BD5NBD
complex, the NBD structure is in the open state, which is similar
to that in the BAG1 BDNBD complex. In the other BD5NBD
complex, the NBD structure is distinct, and the pocket for310 Structure 18, 309–319, March 10, 2010 ª2010 Elsevier Ltd All rights reservedADP/ATP binding is distorted. Actually, it
was demonstrated that the BD5 reduced
the affinity of the NBD for ADP. Therefore,
either or both of the structures may
contribute to the rapid dissociation of
ADP from the NBD. Moreover, we found
that the full-length BAG5, as well as BD5,
enhanced the refolding activity of Hsp70.
Therefore, we concluded that BAG5
assists Hsp70-mediated refolding activity
as the NEF, through the interaction
between the BD5 and the NBD.
RESULTS AND DISCUSSION
The BAG5 BD5 Associates
with the Hsp70 NBD Fragment
BAG5 reportedly interacts with the NBD,
but not with the SBD, of Hsp70 in the
cytosol (Kalia et al., 2004). However, it
has remainedelusive howmany andwhichof the five BDs participate in binding to the NBD. Therefore, we
prepared fragments of BD1 (residues 1–89), BD2–3 (residues
86–260), BD4 (residues 275–350), and BD5 (residues 341–447),
as well as the full-length protein (BAG5 FL; residues 1–447), and
performed invitropull-downassayswith theHsp70NBD (residues
1–388). First, we demonstrated that the purified BAG5 FL associ-
ated with the NBD fragment in vitro. Moreover, as shown in
Figure 1C, the BAG5 BD5 as well as the BAG5 FL pulled down
theNBD,whereas the otherBDsdidnot. Therefore, theBD5binds
to the NBD most strongly among the BAG5 BDs.
Crystal Structure of the BD5NBD Complex
Next, we mixed the recombinant fragments of the Hsp70 NBD
and the BAG5 BD5, and purified the BD5NBD complex. The
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Figure 2. Structural Comparison of the BDs
(A) Comparison of the BAG1 BD (green) and the BAG5 BD5 (magenta).
(B) Comparison of the BAG4 BD (yellow) and the BAG5 BD5.
(C) Solution structure of the BAG5BD1, represented by a cyan ribbon diagram.
(D) Solution structure of the BAG5 BD4, represented by an orange ribbon
diagram.
(E) Solution structure of the BAG3 BD, represented by a gray ribbon diagram.
(F) Comparison of the BAG5 BD1 (cyan) and BD5.
(G) Comparison of the BAG5 BD4 (orange) and BD5.
(H) Comparison of the BAG3 BD (gray) and the BAG5 BD5.
Structure
BAG5-Dependent ADP-ATP Exchange of Hsp70elution pattern of the BD5NBD complex in the gel-filtration
chromatography indicated that the complex contains one
molecule of each protein. An HPLC analysis revealed that neither
ATP nor ADP was detected with the BD5-bound NBD, whereas
ADP was detected with the recombinant NBD fragment itself
(see Figure S1 available online). Therefore, the purified complex
was composed of the BD5 and the NBD in the nucleotide-free
state. We crystallized this sample and collected a 2.3 A˚ native
data set. The crystal structure was solved by the molecular
replacement method, using the program MOLREP (CCP4,
1994). The NBD structure in the complex with the BAG1 BD
(PDB ID: 1HX1) (Sondermann et al., 2001) and the BD5 structure
created by SWISS-MODEL (http://swissmodel.expasy.org//
SWISS-MODEL.html) were used as the search models. After
remodeling the residues of the BD5NBD complex, we refined
it to an R/Rfree of 21.8/28.1. In this crystal, the asymmetric unit
contains two complexes, which are designated as complexes
A and B (Figure 1D).
Comparisons of the BD Structures
As mentioned above, the BDs of BAG5 and BAG3 are shorter
than the BAG1 BD, but are similar to the BAG4 BD (Figure 1B).
First, the present structures of the BD5 complexed with the
NBD were compared with the NMR solution structure of the
BAG1 BD (PDB ID: 1I6Z) (Briknarova´ et al., 2001) and the crystal
structure of the BAG1 BD complexed with the NBD. Actually,
helices a1 and a2 in the BD5 are shorter by 12 and 11 residues,
respectively, than those in the BAG1 BD, while helix a3 is only
two residues shorter (Figure 2A). In contrast, the positions and
directions of the three helices in the BD5 are the same as those
in the BAG1 BD. In contrast, the present BD5 structures are very
similar to the NMR solution structure of the BAG4 BD (PDB ID:
1M62) (Briknarova´ et al., 2002) (Figure 2B).
Next, we determined the NMR solution structures of the
murine BAG5 BD1 (Figure 2C), human BAG5 BD4 (Figure 2D),
andmurineBAG3BD (Figure 2E). All of these structures exhibited
three short a helices, as in those of the BAG4 BD and the BAG5
BD5. In contrast, the BAG3 BD structure superimposed very
well onto the BAG5 BD5 structure (Figure 2H) and the BAG5
BD1 and BD4 assumed almost the same overall structures as
that of the BD5, although the binding of the BD1 or BD4 to the
NBD was not detected. The root mean square deviations of
the BAG5 BD1 and BD4 structures from the BD5 structure in
complex A are no more than 1.1 A˚ (Figure 2F) and 1.5 A˚ (Fig-
ure 2G), respectively.
Interaction between the BD5 and the NBD
TheBAG5BD5aswell as theBAG1BD interactswith theNBDvia
helices a2 (residues 393–411) and a3 (residues 418–442) (Figures
3A–3D). In both complexes A and B, the negatively charged side
chains of Glu399, Glu400, and Asp410 from helix a2 of the BD5
interact with the positively charged side chains of Lys257,
Arg258, Arg261, Arg262, and Arg269 in the NBD (Figures 3A
and 3C), while the side chains of Arg424, Lys425, and Gln432
from helix a3 of the BD5 interact with the negatively charged
side chains of Asp285 and Asp292 and the hydroxyl groups of
Ser286 and Tyr294 in the NBD (Figures 3B and 3D). Next, we
mutated Glu399, Glu400, Asp410, Arg424, and Gln432 in the
BD5 (residues 361–447) to alanine and performed in vitro pull-Structure 18, 3down assays. The D399A and D400A mutations reduced the
NBD binding, and the D410A, R424A, and Q432A mutations
abolished it (Figure 3F). Therefore, these residues of the BD5
are important for the interaction with the NBD. Furthermore,
Glu399, Glu400, Asp410, Arg424, and Gln432 of the BD5 are
conserved in the BAG3 and BAG4 BDs (Figure 3E), suggesting
that their NBD binding modes are almost the same as that
of the BAG5 BD5. In contrast, the other BAG5 BDs lack a few
of the NBD-interacting residues (Figure 3E). The absence of
Glu399 in the BD3 and BD4, Glu400 in the BD1, BD3, and BD4,
Asp410 in the BD2, and Gln432 in the BD1, BD2, and BD4 is
considered to be the reason why these BDs failed to bind the
NBD, in spite of their high structural similarity to the BD5.09–319, March 10, 2010 ª2010 Elsevier Ltd All rights reserved 311
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Figure 3. The Interacting Residues from the Hsp70 NBD and the BAG5 BD5
(A) Close-up view of the interaction between the NBD (green) and helix a2 of the BD5 (magenta) in complex A.
(B) Close-up view of the interaction between the NBD (green) and helix a3 of the BD5 (magenta) in complex A.
(C) Close-up view of the interaction between the NBD (cyan) and helix a2 of the BD5 (orange) in complex B.
(D) Close-up view of the interaction between the NBD (cyan) and helix a3 of the BD5 (orange) in complex B. All stick models indicate interacting residues.
(E) Sequence alignment of helices a2 and a3 in the BDs from human BAG1, BAG3, BAG4, and BAG5 and the positions of the interacting residues in the BDs from
complexes A and B and the BAG1 BDNBD complex (Sondermann et al., 2001).
(F) In vitro binding assay between the purified NBD and His-BD5 mutants. In the lane labeled ‘‘No DNA,’’ the sample synthesized in the Escherichia coli cell-free
protein expression system without DNA was used as a negative control.
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BAG5-Dependent ADP-ATP Exchange of Hsp70Glu399 of the BAG5 BD5 is missing in the BAG1 BD, while it is
conserved in BAG3 and BAG4. The corresponding residue of the
BAG1 BD, Ile211, is not involved in the NBD binding (Sonder-
mann et al., 2001). Therefore, it was suggested that the NBD-
binding mechanism is not exactly the same between the
BAG1 BD and the BAG4 BD (Brockmann et al., 2004), and this
has now been unambiguously demonstrated by the present
BD5NBD complex structures. In the BAG1BD,Glu219 interacts312 Structure 18, 309–319, March 10, 2010 ª2010 Elsevier Ltd All rigwith Arg261 and Thr265 in the NBD. However, Glu219 of the
BAG1 BD is not conserved in the BAG4 BD, BAG5 BD5,
or BAG3 BD and corresponds to a conserved Leu residue
(Leu407 in the BAG5 BD5) (Figure 3E). In fact, Leu407 of the
BD5 is not involved in the NBD binding in the present structures.
Therefore, it is likely that Glu399 (or its equivalent residue) in the
short BDs functionally compensates for the lack of Glu residues
in the other positions corresponding to Glu219 of the BAG1 BD.hts reserved
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Figure 4. Comparison of Overall NBD Structures
(A) Comparison of the NBD structures in complexes A (green) and B (cyan).
(B) Comparison of the NBD structures in complex A and in the ADP-bound
state (violet) (PDB ID: 1HJO) (Osipiuk et al., 1999).
(C) Comparison of the NBD structures in complex A and in the complex with
the BAG1 BD (pink) (PDB ID: 1HX1) (Sondermann et al., 2001).
(D) Comparison of the NBD structures in complex B and in the ADP-bound
state. White-based stick models represent ADP. All structural comparisons
were performed by the superposition of subdomains IA, IB, and IIA, using
the program LSQKAB (CCP4, 1994). As shown in Figures S2 and S3, we
compared the NBD structures in complexes A and B with other reported
NBD structures.
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Structure 18, 3Comparison of the NBD Structures
The Hsp70 NBD is divided into four subdomains, IA (residues
1–39, 116–188, and 361–384), IB (residues 40–115), IIA (residues
189–228 and 307–360), and IIB (residues 229–306). The region
between subdomains IIA and IIB is flexible, and subdomain IIB
can rotate at this hinge region relative to the other subdomains
(Bhattacharya et al., 2009; Xu et al., 2008). Therefore, to compare
the NBD structures in complexes A and B, we superimposed
their IA, IB, and IIA subdomains, using the program LSQKAB
(CCP4, 1994). The position of subdomain IIB relative to the other
three subdomains is apparently different between complexes
A and B, in both the front and side views (Figure 4A).
In order to analyze these NBD structures, we compared each
of them with previously reported NBD structures. First, we
compared the structure of the NBD in complex A (NBD A) with
that of the ADP-bound NBD (PDB ID: 1HJO) (Osipiuk et al.,
1999). When an adenine nucleotide, such as ATP, ADP, and
AMPPNP, binds to the NBD, the adenosine moiety interacts
with subdomain IIB and the phosphate groups interact with sub-
domains IA, IB, and IIA. The nucleotide binding causes subdo-
mains IB and IIB to approach each other, and the NBD structure
adopts the closed state. In contrast, subdomain IIB is rotated by
about 15 in the NBDA, as compared with that in the ADP-bound
NBD (Figure 4B). Second, we compared the structure of the NBD
A with that in the complex with the BAG1 BD (PDB ID: 1HX1)
(Sondermann et al., 2001). As mentioned above, the structure
of the NBD in the complex with the BAG1 BD is in the open state.
The two NBD structures are very similar to each other, indicating
that the structure of the NBD A is also in the open state
(Figure 4C). In this context, an open-state structure of the NBD
has also been reported for a longer fragment covering both the
NBD and SBD of bovine Hsc70 (PDB ID: 1YUW) (Jiang et al.,
2005), which is quite similar to the NBD structure in the BAG1
BDNBD complex (Sondermann et al., 2001) (Figure S2A), as
discussed in Shida et al. (2010). Actually, the present NBD A
structure superimposed slightly better on the BAG1 BDNBD
structure than on the NBD-SBD structure (Figure S2B).
Wenext compared the structure of theNBD in complexB (NBD
B) with that of the ADP-bound NBD. In the front view (Figure 4D,
left), the NBD B appears to be similar to that of the ADP-bound
NBD in the closed state. However, in the side view (Figure 4D,
right), subdomain IIB is rotated by 10 in theNBDB, as compared
with that in the ADP-bound NBD. Therefore, the NBD B structure
is in a distorted state, rather than in the closed state (Figure 4D).
Furthermore, the NBD B structure does not superpose well
with those in the previously reported open-state structures:
the Hsc70 NBD-SBD (PDB ID: 1YUW) (Jiang et al., 2005)09–319, March 10, 2010 ª2010 Elsevier Ltd All rights reserved 313
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Figure 5. Structural Differences between the BD5NBD and BAG1 BDNBD Complexes
(A) Close-up view of Glu399 from the BD5 in complex A (NBD, green; BD5, magenta) and Ile211 from the BAG1 BD in the BAG1 BDNBD complex (NBD, pink;
BAG1 BD, yellow).
(B) Close-up view of Glu399 from the BD5 in complex A (NBD, cyan; BD5, orange) and Ile211 from the BAG1 BD in the BAG1 BDNBD complex (NBD, pink; BAG1
BD, yellow). (A) and (B) were created by the superposition of subdomain IIB of the NBDs.
(C) Close-up view of Asn57 from the NBD and Lys404 from the BD5 in complex A.
(D) Close-up view of Asn57 from the NBD and Lys404 from the BD5 in complex B.
(E) Close-up view of Asn57 from the NBD and Lys404 from the BAG1 BD.
(F) Schematic models of the structures of the BD5NBD and BAG1 BDNBD complexes. As shown in Figure S4, the open state of the NBD Amay be stabilized by
a new hydrogen bond between Gly230 (subdomain IIB) and Ser340 (subdomain IIA).
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BAG5-Dependent ADP-ATP Exchange of Hsp70(Figure S3A), the complex with the BAG2 BNB domain (PDB ID:
3CQX) (Xu et al., 2008) (Figure S3B), and the complex with Sse1
(PDB ID: 3D2F) (Polier et al., 2008) (Figure S3C). In summary,
theNBD in the complexwith theBD5was observed in two states.
In one state, the NBD structure assumes the open form similar to
that in the complex with the BAG1 BD, and in the other state, the
NBD structure assumes a novel, distorted form.
The Difference in the NBD-Binding Modes between
BAG5 BD5 and BAG1 BD
We compared the NBD and BD residues involved in the inter-
action within the BAG1 BDNBD complex, in which the NBD314 Structure 18, 309–319, March 10, 2010 ª2010 Elsevier Ltd All rigassumes the open form (Sondermann et al., 2001; Williamson
et al., 2009), and in the BAG5 BD5NBD complexes A and B
in the open form and the distorted form, respectively. Glu399
in the BD5, which is conserved in the BAG3 and BAG4 BDs,
but not in the BAG1 BD (Figure 3E), interacts with Lys257
and/or Arg258 in the NBD (Figures 3A and 3C). In contrast,
the helix bundle of the BD5 is rotated by about 10 in
complexes A and B, compared with its position in the BAG1
BDNBD complex, as revealed by the superposition of these
structures on subdomain IIB of the NBD (Figures 5A and 5B).
The directional differences can be ascribed to the interaction
through Glu399 in the BD5. In the BAG1 BDNBD complex,hts reserved
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BAG5-Dependent ADP-ATP Exchange of Hsp70Lys216 (equivalent to Lys404 in BAG5 BD5) interacts with
Asn57 in subdomain IB of the NBD in the open state (Fig-
ure 5C). However, because of the upper rotation of the helix
bundle, Lys404 in the BD5 cannot reach Asn57 in subdomain
IB in the NBD A, which assumes the typical open state
(Figure 5D). Thus, the BD5 interacts only with subdomain IIB,
but not at all with subdomain IB, in the NBD A. This open state
may be stabilized by a new hydrogen bond between Gly230
(subdomain IIB) and Ser340 (subdomain IIA) within the NBD
(Figure S4), as pointed out for the other open forms (Shida
et al., 2010). In contrast, in the distorted state, Lys404 in the
BD5 is still able to interact with Asn57 in subdomain IB in
the NBD B (Figure 5E), while subdomains IIA and IIB do not
acquire the hydrogen bond between Gly230 and Ser340.
Therefore, the BD5 may stabilize the distorted state by inter-
acting with both subdomains IB and IIB. In this context, the
BAG1 BD can stabilize the open state of the NBD through
interactions with both subdomains IB and IIB, as well as by
the interaction between subdomains IIA and IIB (Shida et al.,
2010). However, if the NBD in complex with the BD5 assumed
the closed form, as in the ADP-bound NBD structure, then the
BD5 would clash with subdomain IB. Consequently, the BAG5
BD5NBD complex is likely to exist in an equilibrium between
the open and distorted states, but not in the closed state
(Figure 5F).
The Nucleotide-Binding Groove in the Open State
(Complex A) and in the Distorted State (Complex B)
of the BD5NBD Complex
The NBD nucleotide-binding grooves in the open and distorted
states of the BD5NBD complex were examined in comparison
with that in the closed state. In the ADP-bound NBD in the
closed state, the adenosine moiety binds to Glu268, Lys271,
and Ser275 in subdomain IIB, and the diphosphate moiety
binds to Thr13, Thr14, and Tyr15 in subdomain IA and Gly339
in subdomain IIA. ADP brings subdomain IIB near subdomain
IB and, simultaneously, the NBD retains the ADP by maintain-
ing its closed state. In contrast, in complexes A and B, the
adenosine-binding residues shift farther by 4 A˚ and 3 A˚,
respectively, from the diphosphate-binding residues, as com-
pared with those in the ADP-bound NBD (Figure 6A). These
results indicate that the NBD in the distorted state binds ADP
only weakly, as in the case of that in the open state. Therefore,
the BAG5 BD5 seems to accelerate the release of ADP from the
NBD, either in the open state or in the distorted state. In other
words, the BD5 and ADP compete with each other for binding
to the NBD.
One of the possible scenarios of nucleotide exchange is as
follows. First, the BD5 associates with the ADP-bound NBD
and induces the distorted form through interactions with both
subdomains IB and IIB. Then, after the ADP dissociation, the
BD5 may disengage first from subdomain IB, as in the open
form of the NBD A, which may be stabilized by the interaction
between subdomains IIA and IIB. Finally, the BD5 dissociates
from subdomain IIB, when ATP rebinds to the NBD and induces
its closed form. In this scenario, the two states observed in
complexes B and A would thus represent successive states in
the conformational trajectory of the NBD upon interaction with
the BD5.Structure 18, 3BD5 Functions as the Nucleotide Exchange Factor
of Hsp70
We demonstrated the effect of the BD5 on the affinity of the
NBD for ADP by an isothermal titration calorimetry (ITC) assay.
We titrated the NBD fragment solution (10 mM) with the ADP
solution (400 mM) and obtained an affinity of 42.7 nM and a stoi-
chiometry factor of approximately 1 (Figure 6B). Next, we
titrated the BD5NBD complex solution (10 mM) with the ADP
solution (400 mM). The curve of heat changes was fitted using
a one-site binding model and demonstrated an affinity of 508
nM and a stoichiometry factor of approximately 1 (Figure 6C).
This indicated that the presence of the BD5 reduced the affinity
of the NBD for ADP. The BD5 also reduced the affinity of
the NBD for ATP. Nevertheless, ATP is present in an excess
amount in the cytosol and may still bind to the BD5NBD com-
plex. Actually, an in vitro pull-down assay revealed that an
excess amount of ATP dissociated the BD5 from the NBD (Fig-
ure 6D). Therefore, the BD5 promotes the release of ADP and
the entry of ATP, by disrupting the nucleotide-binding groove
in the NBD.
In order to examine the effect of the BD5 on the chaperone
activity of Hsp70, we refolded heat-denatured luciferase with
Hsp70 in vitro and added the BD5 to the refolding reaction.
The addition of the BD5 noticeably increased the luciferase
activity (Figure 6E). Next, we added the D410A mutant of the
BD5, which was defective in binding to the NBD in our pull-
down assay, to the refolding reaction. As a result, the addition
of the BD5 mutant did not increase the luciferase activity
(Figure 6E). Therefore, the BD5 activates the Hsp70-mediated
refolding by enhancing the exchange of ADP to ATP. That is,
the BD5 functions as the NEF of Hsp70.
BD5 Is Responsible for the Function of BAG5with Hsp70
Finally, we examined the effect of the full-length BAG5, with the
BD1–BD5, on the Hsp70 chaperone activity. As in the case of the
BD5, the full-length BAG5 with the D410A mutation was unable
to associate with the NBD (Figure 7A). Consequently, the BD5,
but not the other BDs, is responsible for the binding of BAG5
with the NBD. Furthermore, the refolding of heat-denatured lucif-
erase by Hsp70 in vitro was enhanced by BAG5, but not by its
D410A mutant (Figure 7B). Therefore, BAG5 enhances the
Hsp70 chaperone activity through the interaction of its BD5
with the NBD.
In summary, our biochemical assays and the crystal struc-
ture of the BD5NBD complex revealed that BAG5 interacts
with the Hsp70 NBD through the BD5, facilitates the unique
conformational change in the NBD, promotes the ADP release
and the ATP entry, and activates the Hsp70-mediated refold-
ing in vitro. Thus, we concluded that BAG5 activates Hsp70-
mediated refolding, as the NEF (Figure 7C). BAG5 is usually
expressed in various tissues, and cellular injury induces
BAG5 expression (Kalia et al., 2004), which suggests that the
role of BAG5 in the normal cells is to assist the cellular
Hsp70 chaperone system. This molecular function of BAG5
should be taken into account to understand how overexpres-
sion of BAG5 causes protein aggregation in dopaminergic
neurons and the neurodegeneration associated with endo-
plasmic reticulum stress (Chung and Dawson, 2004; Kalia
et al., 2004).09–319, March 10, 2010 ª2010 Elsevier Ltd All rights reserved 315
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Figure 6. Mechanism of the BD5-Mediated
Nucleotide Exchange
(A) Stereo view of the nucleotide-binding grooves
of the NBD A (green), the NBD B (cyan), and the
ADP-bound state (violet). The white-based stick
model represents ADP, and the other stick models
indicate ADP-interacting residues.
(B) ITC analysis of the interaction of the Hsp70 NBD
with ADP.
(C) ITC analysis of the interaction of the NBD with
ADP in the presence of the BAG5 BD5.
(D) In vitro pull-down assay between the NBD
and His-BD5 in the presence of ATP. The con-
centrations of ATP in lanes 1–8 are 0 M, 5 mM,
10 mM, 20 mM, 40 mM, 80 mM, 160 mM, and 1 mM,
respectively.
(E) Effect of the BAG5 BD5 on Hsp70-mediated
refolding activity, measured by denatured lucif-
erase. ‘‘None’’ indicates the activity of denatured
luciferase incubated with no chaperone. ‘‘Hsp70’’
indicates the activity of denatured luciferase
incubated with Hsp70 and Hsp40. ‘‘+ BD5 WT’’
indicates the activity of denatured luciferase incu-
bated with Hsp70, Hsp40, and the BAG5 BD5. ‘‘+
BD5 D410A’’ indicates the activity of denatured
luciferase incubated with Hsp70, Hsp40, and the
D410A mutant of the BAG5 BD5. The activity of
luciferase incubated with Hsp70 and Hsp40 for
40 min was set to 1 and n = 5. The error bars repre-
sent the standard errors.
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Expression Vectors
The DNA regions encoding human Hsp70, the NBD (residues 1–388), and
Hsp40 were cloned into pENTR/TEV/D-TOPO (Invitrogen). Their expression
vectors were constructed using GATEWAY technology (Invitrogen) with the
pET-32/GATEWAY vector, which was inserted into the GATEWAY reading
frame cassette A (Invitrogen) in pET-32a (+) (Novagen) (Shida et al., 2010).
The DNA regions encoding human BAG5 FL, BD1 (residues 1–86), BD2–3
(residues 86–260), BD4 (residues 275–350), and BD5 (residues 341–447 and
residues 361–447) and murine BAG5 BD1 (residues 1–86) and BAG3 BD (re-
sidues 406–503), as the N-terminal fusion with a histidine affinity tag,
a tobacco etch virus (TEV) protease cleavage site, and seven extra residues
(GSSGSSG), were cloned into the pCR2.1-TOPO vector using a TOPO TA
cloning kit (Invitrogen). The point mutations of the BAG5 FL and BD5 were316 Structure 18, 309–319, March 10, 2010 ª2010 Elsevier Ltd All rights reservedintroduced using QuickChange (Stratagene) muta-
genesis and were verified by DNA sequencing.
In Vitro Pull-down Assay
The expression of human BAG5 FL, BD1 (residues
1–89), BD2–3 (residues 86–260), BD4 (residues
275–350), and BD5 (residues 341–447) and the
D410A mutants of the BAG5 FL and BD5 was
accomplished with the Escherichia coli cell-free
protein expression system (Kigawa et al., 2004,
2007) at 30C for 4 hr. After cell-free synthesis,
the reaction solutions were clarified by centrifuga-
tion. ProBond Nickel-Chelating Resin (Invitrogen),
equilibratedwith wash buffer [25mMsodium phos-
phate buffer (pH 8.0) containing 150 mM NaCl and
10 mM imidazole], was mixed with the superna-
tants, washedwith thewash buffer, and thenmixed
with the NBD and purified as described below.
After incubating the mixture at 4C for 2 hr and
washing with the wash buffer, the proteins bound to the resins were eluted
with elution buffer [25 mM sodium phosphate buffer (pH 8.0) containing
150 mM NaCl and 200 mM imidazole]. Finally, we performed SDS-PAGE
and CBB staining to detect the NBD.
Purification of the BD5NBD Complex
The expression of the Hsp70 NBD was performed in Escherichia coli Rosetta2
(DE3) cells by induction with 0.5 mM IPTG overnight at 18C, and the expres-
sion of the BAG5BD5was performed in Escherichia coliKRX cells by induction
with 0.1% rhamnose overnight at 18C.
Next, we purified the BAG5 BD5 (residues 341–447) and Hsp70 NBD sepa-
rately. The cells were harvested by centrifugation and suspended in 20 mM
Tris-HCl buffer (pH 8.0), containing 500 mM NaCl, 5 mM imidazole, and
5 mM b-mercaptoethanol. The cells were lysed by sonication and cleared by
centrifugation and filtration. The clarified lysates were loaded on a HisTrap
input
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Figure 7. The Effect of BAG5 on Hsp70 Chaperone
Activity
(A) In vitro pull-down assay, using the His-tagged BAG5 FL
and the D410A mutant and the purified Hsp70 NBD.
In the lane labeled ‘‘No DNA,’’ the sample synthesized in
the Escherichia coli cell-free protein expression system
without DNA was used as a negative control.
(B) Effect of BAG5 on Hsp70-mediated refolding activity,
measured by denatured luciferase. ‘‘None’’ indicates the
activity of denatured luciferase incubated with no chap-
erone. ‘‘Hsp70’’ indicates the activity of denatured lucif-
erase incubated with Hsp70 and Hsp40. ‘‘+ BAG5 WT’’
indicates the activity of denatured luciferase incubated
with Hsp70, Hsp40, and the BAG5 FL. ‘‘+ BAG5 D410A’’
indicates the activity of denatured luciferase incubated
with Hsp70, Hsp40, and the D410A mutant of the BAG5
FL. The activity of luciferase incubated with Hsp70 and
Hsp40 for 40 min was set to 1 and n = 5. The error bars
represent the standard errors.
(C) Schematic models of the nucleotide exchange mecha-
nism of BAG5.
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BAG5-Dependent ADP-ATP Exchange of Hsp70column (GE Healthcare) and were eluted with an imidazole gradient from 5mM
to 500 mM. Fractions containing the BD5 or NBD protein were pooled sepa-
rately, and TEV protease was added to the protein solutions. The samples
were dialyzed against 20 mM Tris-HCl buffer (pH 8.0), containing 25 mM
NaCl and 5 mM b-mercaptoethanol, overnight at 4C. After centrifugation
and filtration, the clarified samples were loaded on the HisTrap column again
to remove the TEV protease and the cleaved His tag. The samples were then
loaded on a Resource Q column (GE Healthcare) and eluted with an NaCl
gradient from 25 mM to 1 M. The fractions containing the BD5 or NBD protein
were pooled, concentrated to less than 5 ml by centrifugation in an Amicon
ultra filter (Millipore), filtered, loaded on a HiLoad 16/60 Superdex 200 column
(GE Healthcare), and eluted with 20 mM Tris-HCl buffer (pH 8.0), containing
150 mM NaCl and 5 mM b-mercaptoethanol.
After purifying the NBD and BD5 proteins separately, we mixed them in
a one to one ratio and incubated the solution at 4C for 2 hr. This sample
was loaded on a HiLoad 16/60 Superdex 200 column and eluted with
20mM Tris-HCl buffer (pH 8.0), containing 150mMNaCl and 5 mM b-mercap-
toethanol, and the fractions containing the BD5NBD complex were pooled.
Crystallization, Data Collection, Model Building, and Refinement
The protein sample was concentrated to 5.5 mg/ml and was crystallized by the
hanging drop vapor diffusion method at 293 K against a reservoir solution
[0.1 M Tris-HCl buffer (pH 8.0) containing 20% PEG MME 2000, 0.25 M trime-
thylamine N-oxide, and 3% hexanediol]. The crystal belongs to the space
group P21, with unit-cell parameters a = 64.11 A˚, b = 84.27 A˚, c = 96.63 A˚,
a = g = 90.0, and b = 100.7, and there are two BD5NBD complexes in the
asymmetric unit.
All diffraction data were recorded at 100 K, with the reservoir solution con-
taining 15% glycerol as a cryoprotectant. X-ray diffraction data were collected
at a 1.0 A˚ wavelength at BL26B2 of SPring-8 and were processed with the
HKL2000 and SCALEPACK programs (Otwinowski and Minor, 1997).
The crystal structure of the BD5NBD complex was determined by the
molecular replacement method, using the MOLREP program (Vagin and
Teplyakov, 1997). The NBD structure in the complex with the BAG1 BD
(PDB ID: 1HX1) (Sondermann et al., 2001) and the BD5 structure created by
SWISS-MODEL were used as the search models. After several rounds of
manual revisions of the model using the TURBO-FRODO program and refine-Structure 18, 309–319, March 1ments using the CNS programs (BrU¨nger et al., 1998), the
Rwork and Rfree were 21.8% and 28.1%, respectively, and
the refined structure had no Ramachandran violations, as
examined by the PROCHECK program (Laskowski et al.,
1996). Crystallographic data collection and refinement
statistics are summarized in Table 1. The crystal structureof the BD5NBD complex has been deposited in the Protein Data Bank
(PDB code: 3A8Y).
NMR Spectroscopy, Structure Determination, and Analysis
All of the NMR spectra were recorded at 25C on Varian INOVA 600, 800, and
900 spectrometers equipped with pulse-field gradient triple-resonance
probes. Sequence-specific resonance assignments were made using the
standard triple-resonance techniques. The backbone assignment was
achieved by the combined analysis of HNCO, (HCA)CO(CA)NH, HN(CO)CA,
HNCACB, and CBCA(CO)NH spectra. The side-chain resonances were iden-
tified by the combined use of HBHANH, HBHA(CO)NH, (H)CC(CO)NH,
(H)CCH-TOCSY, HCCH-TOCSY, and two-dimensional 1H-15N HSQC and
1H-13C HSQC spectra. NOE data for structure determination were extracted
from three-dimensional 15N- and 13C-edited NOESY spectra, recorded with
mixing times of 75 and 65 ms, respectively, for BAG5 BD4, and 75ms for
both BAG3 BD and BAG5 BD1. The NMRPipe software package (Delaglio
et al., 1995) and the program KUJIRA (Kobayashi et al., 2007), created on
the basis of NMRView (Johnson and Blevins, 1994), were used for optimal
visualization and spectral analysis. Automated NOE cross-peak assignments
(Herrmann et al., 2002) and structure calculations with torsion angle dynamics
were performed using the software package CYANA1.0.7 for BAG3 BD and
BAG5 BD1 and CYANA2.0.17 for BAG5 BD4 (GU¨ntert, 2003).
Dihedral angle restraints were derived using the program TALOS (Cornilescu
et al., 1999). A total of 100 conformers were calculated independently. The 20
conformers with the lowest final CYANA target function values were finally
selected. The structures were validated using PROCHECK-NMR (Laskowski
et al., 1996). The program MOLMOL (Koradi et al., 1996) was used to analyze
the resulting 20 conformers. The selected 20 conformers have been deposited
in the Protein Data Bank (PDB codes: 1UK5 for BAG3 BD, 1UGO for BAG5
BD1, and 2D9D for BAG5 BD4).
ITC Measurements
The interaction between the NBD and ADP was monitored by ITC measure-
ments (Wiseman et al., 1989), performed at 25C with a Microcal VP-ITC
calorimeter. Samples were buffered with 20 mM Tris-HCl buffer (pH 8.0), con-
taining 150 mM NaCl, 5 mMMgCl2, and 1 mM DTT. Aliquots of a 400 mM ADP
solution (syringe) were stepwise injected into a 10 mM NBD solution with or0, 2010 ª2010 Elsevier Ltd All rights reserved 317
Table 1. Crystallographic Data and Refinement Statistics
The BD5NBD Complex
Data collection
Beamline SPring-8 BL26B2
Space group P21
Unit cell
a, b, c (A˚) 64.11, 84.27, 96.63
a, b, g () 90.0, 100.7, 90.0
Resolution (A˚) 50–2.30 (2.38–2.30)a
No. of measured reflections 118,991
No. of unique reflections 42,589
Redundancy 2.79
Completeness (%) 94.5 (85.2)a
I/s (I) 21.2 (4.1)a
Rsym
b (%) 4.7 (18.1)a
Refinement statistics
Resolution (A˚) 19.98–2.30
No. of reflections 42,522
No. of protein atoms 2,134
No. of Tris molecules 2
No. of water molecules 522
Rwork/Rfree
c (%) 21.8/28.1
Rmsd bond length (A˚) 0.006
Rmsd bond angles () 1.2
Average isotropic B value (A˚2) 40.2
Ramachandran plot
Most favored regions (%) 86.3
Additional allowed regions (%) 13.4
Generously allowed regions (%) 0.3
Disallowed regions (%) 0
PDB code 3A8Y
aStatistics for the highest resolution shell are given in parentheses.
b Rsym = SjI  < I >j/SI, where I is the observed intensity of reflections.
c Rwork, Rfree =SjFobs Fcalcj/SFobs, where the crystallographic R factor is
calculated including and excluding refinement reflections. In each refine-
ment, free reflections consist of 5% of the total number of reflections.
Structure
BAG5-Dependent ADP-ATP Exchange of Hsp70without 10 mM BD5 protein (cell). The heat generated due to the dilution of the
ADP solution was quite small and was ignored for the analysis. The data were
analyzed with the Microcal ORIGIN software, using a binding model that
assumes a single site of interaction.
Refolding Assay
Luciferase (13mg/ml) (Promega)wasdiluted42-foldwith 30mMHEPES-NaOH
buffer (pH 7.5), containing 50 mM KCl, 6 M Urea, and 10 mM MgCl2, and was
denatured at 42C for 30 min. The denatured luciferase was diluted 250-fold
with 30 mM HEPES-NaOH and 1 mM Tris-HCl buffer (pH 7.5), containing
50 mM KCl, 10 mM MgCl2, 2 mM DTT, 1 mM Hsp70, 2 mM Hsp40, and 0.2 mM
of the BAG5 FL, BD5, and their mutants, and was refolded at 30C. The lucif-
erase activity was determined with a Luciferase assay kit (Promega).
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